Similar articles

• Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus.

  Baker CJ, Rench MA, Edwards MS, Carpenter RJ, Hays BM, Kasper DL. Baker CJ, et al. N Engl J Med. 1988 Nov 3;319(18):1180-5. doi: 10.1056/NEJM198811033191802. N Engl J Med. 1988. PMID: 3050524
• Response to type III polysaccharide in women whose infants have had invasive group B streptococcal infection.

  Baker CJ, Rench MA, Kasper DL. Baker CJ, et al. N Engl J Med. 1990 Jun 28;322(26):1857-60. doi: 10.1056/NEJM199006283222606. N Engl J Med. 1990. PMID: 2190087 No abstract available.
• Neonatal group B streptococcal infection prevention.

  Erramouspe J, Lourwood DL. Erramouspe J, et al. Ann Pharmacother. 1994 Apr;28(4):474-5. Ann Pharmacother. 1994. PMID: 8038472 Review. No abstract available.
• [Hope of a vaccine against neonatal GBS infection].

  Källman J, Schollin J, Kihlström E. Källman J, et al. Lakartidningen. 1995 Jul 26;92(30-31):2819-24. Lakartidningen. 1995. PMID: 7643690 Review. Swedish. No abstract available.
• Group B streptococcal disease: its importance in the developing world and prospect for prevention with vaccines.

  Walsh JA, Hutchins S. Walsh JA, et al. Pediatr Infect Dis J. 1989 May;8(5):271-7. Pediatr Infect Dis J. 1989. PMID: 2657615 Review. No abstract available.